Skip to main content

Table 1 Cox univariate and multivariate analysis of biochemical recurrence free survival and progression free survival according to RBM3 expression

From: High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression

  

Progression free survival

RBM3 intensity*fraction dichotomized

HR (95% CI)

p-value

 

n (events)

  

Univariate

   

Low (0-2)

64 (18)

1.00

 

High (3-8)

24 (1)

0.09 (0.01-0.71)

0.021

Multivariate

   

Low (0-2)

64 (16)

1.00

 

High (3-8)

24 (1)

0.06 (0.01-0.50)

0.009

  

BCR free survival

RBM3 intensity*fraction continuous

HR (95% CI)

p-value

 

n (events)

  

Univariate

88 (14)

0.56 (0.34-0.93)

0.024

Multivariate

88 (12)

0.41 (0.19-0.89)

0.024

  1. Multivariate analysis including adjustments for preoperative PSA level, Gleason score, presence or absence of extracapsular extension, seminal vesicle invasion and positive surgical margins.